Force is the trusted partner of Family Offices
Discover all the benefits that have made Force Family Office an important resource for some of the largest and most influential family offices in the world.
Bringing Family Offices Together Since 2012
FORCE was built with the mission to create meaningful relationships between family offices. These relationships enable the exchange of valuable insights, best practices, and investment opportunities, which lead to better-informed decisions. We host more than 150 in-person and online events each year to help families in our community build bridges with one another and contribute to long-term sustainability and success, both financially and in terms of legacy preservation.
Sign up for our weekly newsletter
Members of our Community Experience a Multitude of Benefits
“FORCE is a trusted partner with expertise in family offices that is unparalleled in the investment community. Their events have helped us successfully network with other family offices to find outstanding co-investment opportunities.”
"In terms of creating a dynamic community of family offices, FORCE is an industry leader. You'd be hard pressed to find a group more knowledgeable than FORCE."
"FORCE does much more than introduce us to interesting companies; their educational- and philanthropically-focused events keep us up-to-speed on the trends in play as well as allow us to discover new ways to make a difference in our global community."
Upcoming Events

Family Office Breakfast Chicago
October 7, 2026
A breakfast networking event to foster connections and cultivate mutually beneficial relationships between Family Offices in Chicago

20/20 BioLabs
October 7, 2026
OneTest measures established protein tumor markers and uses machine learning to identify patterns associated with multiple cancers.

SonicTrek
October 7, 2026
SonicTrek is launching an AI-powered platform that enable creators to operate personalized 24/7 audio channels in their own voice.

Kesmalea Therapeutics
October 13, 2026
Kesmalea is developing an oral therapeutic designed to selectively eliminate a protein strongly associated with Alzheimer’s progression

Trethera
October 14, 2026
A first-in-class oral therapy for cancer, neuroinflammatory, and autoimmune disease with both FDA Fast Track and Orphan Drug designations

HDT Bio
October 14, 2026
HDT Bio is developing a new immune-maintenance therapy for breast cancer patients designed to prevent relapse years after successful treatment.